Skip to main content
. 2019 May 3;20:255. doi: 10.1186/s13063-019-3329-0

Table 1.

Outcomes and measurements

Outcomes Measurements
1. Primary TWA MAP drop under 65 mmHg threshold Intraoperative record from EV1000 monitor, Edwards Lifesciences
2. Secondary TWA MAP drop under 60 mmHg threshold Intraoperative record from EV1000 monitor, Edwards Lifesciences
TWA MAP drop under 55 mmHg threshold Intraoperative record from EV1000 monitor, Edwards Lifesciences
3. Exploratory Composite of death, stroke, or MINS From Cleveland Clinic Perioperative Health Documentation System PHDS and troponin first three postoperative mornings while in hospital from EHR
Acute kidney injury AKIN, creatinine
Quality of recovery (QoR-15) POD 3, patient interview
Post-operative morbidity survey (POMS) POD 3, EHR
Transfusion requirements (ml) From PHDS
Amounts of intraoperative crystalloid and colloid (ml) From PHDS
Amount of vasoactive: phenylephrine, ephedrine, nor-epinephrine, epinephrine, dobutamine (mg) From PHDS
Advanced hemodynamic variables From EV100
Hospital length of stay From PHDS
Hospital readmission within 30 days From EHR

AKIN Acute Kidney Injury Network, EHR electronic health record, MAP mean arterial pressure, MINS myocardial injury in non-cardiac surgery, PHDS Perioperative health documentation system, PHDS POD post-operative day, TWA time-weighted average